Phase II Investigation definition

Phase II Investigation has the meaning ascribed to such term in Section 5.17(b).
Phase II Investigation has the meaning set forth in Section 7.1.f. of this Agreement.
Phase II Investigation means the in-depth investigation by the European Commission pursuant to Article 6(1)(c) of the EU Merger Regulation, or, in case the European Commission makes a referral in whole or in part under article 4 or 9 of the EU Merger Regulation, an in-depth investigation by the Dutch Competition Authority pursuant to Article 37(2) of the Dutch Competition Act and, if applicable, a similar in-depth investigation by other Regulatory Authorities of Member State(s) to which the transaction may be referred. Position Statement means the position statement of the Boards to be issued in connection with the Offer.

Examples of Phase II Investigation in a sentence

  • A plan indicating the areas of investigation, proposed locations of testing and types of testing shall accompany the Phase II Investigation Plan.

  • A Phase II Investigation Plan shall include a narrative describing the types of features to be investigated, their locations, the types of direct/indirect methods to be used and the reasons for their use.

  • At the completion of the Phase II Investigation, a formal Geotechnical Evaluation Report shall be submitted which shall include a geologic interpretation of the observed subsurface conditions, including soil and rock type, geologic unit, jointing, faulting, voids, fracturing, grain size and sinkhole formation.

  • In addition, the report shall include the geological professional’s recommendations as to whether, in light of the proposed development plan, a Phase II Geological Investigation should be prepared and submitted, and whether any portion of the requirements of the Phase II Investigation should be waived.

  • The purpose of the Phase II Investigation is to delineate and define karst features noted or suspected in the Phase I Geological Investigation, to evaluate the effects of those features on the proposed development, and to propose methods of protection and mitigation if needed.

  • The Municipal Engineer shall determine whether a Phase II Investigation shall be required, based on the data submitted and the recommendation of the applicant’s geological professional.

  • In the event that a Phase II Investigation is not required, the Municipal Engineer shall provide written certification that the applicant has satisfactorily completed the requirements of the Geotechnical Investigation.

  • After the Phase II Investigation Plan has been approved by the Municipal Engineer, formal notification shall be issued to the applicant authorizing the commencement of the testing procedures.

  • Where further investigation is recommended in the Preliminary Risk Assessment, no development shall commence until a suitable Intrusive Investigation (Phase II Investigation Report) has been submitted by the developer to and approved in writing by the planning authority.

  • If initial soil samples are found to have concentrations of any contaminants exceeding any soil remediation standard, then a recommendation to conduct a Remedial Investigation of Soil pursuant to N.J.A.C. 7:26E-4.2, shall be submitted by Contractor for possible Phase II Investigation, for which consultant hiring will be considered under a Contract Amendment.


More Definitions of Phase II Investigation

Phase II Investigation. Report Former Bury & Xxxxxxx Asphalt Plant" January 24, 1995, Xxxx & Associates, Inc. Xxxx & Associates, Inc. "Subsurface Investigation Report Former Bury & Xxxxxxx Asphalt Plant (MPCA Site ID# LEAK 00003598)" April 29, 1992, Xxxxx Intertec Environmental, Inc. "1991 Annual Report for Continued Groundwater Monitoring Former Bury & Xxxxxxx Asphalt Plant" April 29, 1992, Xxxxx Intertec Environmental, Inc. "A Report to City of Golden Valley 1990 Annual Report Former Bury & Xxxxxxx Asphalt Plant" May 23, 1991, Xxxxx Intertec Environmental, Inc. "Underground Storage Tank Excavation Former Bury & Xxxxxxx Asphalt Plant" August 30, 1990, Xxxxx Intertec Environmental, Inc. "EG-292 Site Study and Closure Plan Bury & Xxxxxxx Asphalt Plant Property Golden Valley, Minnesota" September 20, 1989, Xxxxx Environmental Laboratories, Inc. "EG-168 Environmental Evaluation Bury Xxxxxxx Site Golden Valley Minnesota" June 28, 1989, Xxxxx Environmental Laboratories, Inc. "Contaminated Soil Excavations Bury & Xxxxxxx Asphalt Plant" December 1, 1987, Xxxxx Environmental Laboratories, Inc.
Phase II Investigation an in-depth investigation of the effects of the Offer on the relevant markets, following completion of an initial review, as applicable under the laws of the respective jurisdiction; "Registrar of Companies" the Registrar of Companies in England and Wales; "Regulatory Information Service" a "primary information provider" which has been approved by the FCA as such to disseminate regulated information; "Resolution(s)" such shareholder resolution(s) of Xpediator as are necessary to approve, implement and effect the Scheme, including (without limitation) a resolution to make certain amendments to the articles of association of Xpediator;

Related to Phase II Investigation

  • Remedial investigation means a process to determine the nature and extent of a discharge of a contaminant at a site or a discharge of a contaminant that has migrated or is migrating from the site and the problems presented by a discharge, and may include data collected, site characterization, sampling, monitoring, and the gathering of any other sufficient and relevant information necessary to determine the necessity for remedial action and to support the evaluation of remedial actions if necessary;

  • clinical investigation means any systematic investigation in one or more human subjects, undertaken to assess the safety or performance of a device;

  • Background investigation means the investigation conducted by a licensee or applicant to support the determination of trustworthiness and reliability.

  • Complaint Investigation means an investigation of any complaint that has been made to a proper authority that is not covered by an abuse investigation.

  • Site investigation means the collection and evaluation of data adequate to determine whether or not discharged contaminants exist at a site or have migrated or are migrating from the site at levels in excess of the applicable remediation standards. A site investigation shall be developed based upon the information collected pursuant to the preliminary assessment;

  • Phase II means the second part of the tuition incentive assistance program which provides assistance in the third and fourth year of 4-year degree programs.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Phase I Environmental Site Assessment is an assessment of the environmental condition of the Property performed in accordance with the American Society of Testing and Materials (ASTM) Standard E1527-05 “Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process,” or any successor to such ASTM Standard which is active at the time of the assessment.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase I means the first part of the tuition incentive assistance program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate.

  • Phase I Environmental Assessment A “Phase I assessment” as described in, and meeting the criteria of, the ASTM, plus a radon and asbestos inspection.

  • Investigations The Xxxxxxx, when requested by one or a number of employees whom he/she represents, may investigate the basis for any dispute arising under this Agreement and may, at any stage, assist the employee(s) in seeking resolution of such dispute through the grievance procedure provided herein. A representative of the Union may substitute in place of the Xxxxxxx.

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • Initial Environmental Examination or “IEE” means the initial environmental examination for the Project, including any update thereto, prepared and submitted by the Borrower and cleared by ADB;

  • Investigation means a process conducted for the purpose of accident and incident prevention which includes the gathering and analysis of information, the drawing of conclusions, including the determination of causes and, when appropriate, the making of safety recommendations;

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Environmental Report means a report by an Independent Person who regularly conducts environmental site assessments in accordance with then current standards imposed by institutional commercial mortgage lenders and who has a reasonable amount of experience conducting such assessments.

  • EXPERIMENTAL OR INVESTIGATIONAL means any healthcare service that has progressed to limited human application, but has not been recognized as proven and effective in clinical medicine. See Experimental or Investigational Services in Section 3 for a more detailed description of the type of healthcare services we consider experimental or investigational.

  • Studies means activities needed to prepare project implementation, such as preparatory, mapping, feasibility, evaluation, testing and validation studies, including in the form of software, and any other technical support measure, including prior action to define and develop a project and decide on its financing, such as reconnaissance of the sites concerned and preparation of the financial package;

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Environmental Review means the Federal

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.